Precigen, Inc. financial data

Symbol
PGEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
20374 Seneca Meadows Parkway, Germantown, Maryland
State of incorporation
Virginia
Fiscal year end
December 31
Former names
INTREXON CORP (to 1/22/2020)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 218 % +8.66%
Debt-to-equity 35.3 % -28.4%
Return On Assets -98.5 % -1128%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 253M shares -1.07%
Common Stock, Shares, Outstanding 253M shares -1.11%
Entity Public Float 177M USD +9.38%
Weighted Average Number of Shares Outstanding, Basic 252M shares +1.76%
Weighted Average Number of Shares Outstanding, Diluted 252M shares +1.76%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 22.1M USD -39.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -137M USD -88.2%
Income Tax Expense (Benefit) -2.06M USD -1169%
Net Income (Loss) Attributable to Parent -135M USD -711%
Earnings Per Share, Basic -0.54 USD/shares -460%
Earnings Per Share, Diluted -0.54 USD/shares -460%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.35M USD -43.5%
Cash, Cash Equivalents, and Short-term Investments 19.5M USD
Accounts Receivable, after Allowance for Credit Loss, Current 511K USD -62.3%
Assets, Current 23.7M USD -77.5%
Property, Plant and Equipment, Net 13.5M USD +105%
Operating Lease, Right-of-Use Asset 5.55M USD -27.2%
Intangible Assets, Net (Excluding Goodwill) 5.09M USD -88.1%
Goodwill 24.9M USD -32.6%
Other Assets, Noncurrent 435K USD -54.2%
Assets 73.2M USD -64.7%
Accounts Payable, Current 4.85M USD +93.1%
Employee-related Liabilities, Current 6.68M USD +38.5%
Contract with Customer, Liability, Current 378K USD +2420%
Liabilities, Current 23M USD -25.2%
Contract with Customer, Liability, Noncurrent 1.82M USD 0%
Deferred Income Tax Liabilities, Net 77K USD -96.5%
Operating Lease, Liability, Noncurrent 5.07M USD -22.5%
Other Liabilities, Noncurrent 50K USD -50%
Liabilities 30M USD -27.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.91M USD -15.5%
Retained Earnings (Accumulated Deficit) -2.05B USD -7.08%
Stockholders' Equity Attributable to Parent 43.2M USD -74%
Liabilities and Equity 73.2M USD -64.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.1M USD +23.4%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 24M USD
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 256M shares +0.36%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.9M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.61M USD -43.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3M USD +225%
Deferred Tax Assets, Valuation Allowance 424M USD +5.82%
Deferred Tax Assets, Gross 434M USD +5.67%
Operating Lease, Liability 6.34M USD -20.4%
Depreciation 1.61M USD -23.7%
Payments to Acquire Property, Plant, and Equipment 4.35M USD +2725%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -136M USD -661%
Lessee, Operating Lease, Liability, to be Paid 8.58M USD -22%
Property, Plant and Equipment, Gross 35.7M USD +14.9%
Operating Lease, Liability, Current 1.27M USD -10.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.47M USD -22.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.61M USD -20.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Deferred Income Tax Expense (Benefit) -29K USD +47.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.24M USD -26.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.3M USD -13.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.26M USD +1.78%
Operating Lease, Payments 572K USD +23.5%
Additional Paid in Capital 2.09B USD +0.61%
Amortization of Intangible Assets 4.85M USD +2.34%
Depreciation, Depletion and Amortization 1.6M USD -6.78%
Deferred Tax Assets, Net of Valuation Allowance 9.1M USD -0.8%
Share-based Payment Arrangement, Expense 9.11M USD -5.59%